First-line serplulimab plus HLX04 and XELOX versus placebo plus bevacizumab and XELOX in metastatic colorectal cancer: A phase 2/3 study.
- Resource Type
- Article
- Authors
- Xu, Rui-Hua; Wang, Feng; Peng, Junjie; Liang, Xinjun; Cheng, Ying; Deng, Yanhong; Chen, Kehe; Zhang, Mingjun; Zhang, Jingdong; Wang, Wei; Cao, Bangwei; Jin, Yongdong; Sun, Meili; Lin, Yuan; Luo, Su-Xia; Li, Zhen; Yang, Liu; Wang, Qingyu; Li, Jing; Zhu, Jun
- Source
- Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p124-124, 235p
- Subject
- Language
- ISSN
- 0732183X